Plasma Levobunolol Levels following Topical Administration with Reference to Systemic Side Effects

Ophthalmologica - Tập 194 Số 4 - Trang 194-200 - 1987
Gary D. Novack1, Diane Tang-Liu1, Elaine P. Kelley1, Sandra S. Liu1, David Shen1, Efraim Duzman1
1Departments of Ophthalmology Clinical Research and Drug Metabolism and Pharmacokinetics, Allergan Pharmaceuticals, a division of Allergan Incorporation, Irvine, Calif., USA

Tóm tắt

Từ khóa


Tài liệu tham khảo